Variable | All patients | Children and adolescents | Adults |
---|---|---|---|
Hazard ratio (95 % CI) | Hazard ratio (95 % CI) | Hazard ratio (95 % CI) | |
Age category, years | |||
0–19 | 1.00 | – | – |
20–29 | 1.39 (0.84–2.31) | – | – |
30–39 | 1.92 (1.20–3.07)** | – | – |
40–49 | 2.12 (1.32–3.43)** | – | – |
50–59 | 2.73 (1.68–4.45)*** | – | – |
60–69 | 4.98 (3.08–8.05)*** | – | – |
≥ 70 | 8.48 (5.27–13.64)*** | – | – |
Sex | |||
Female | 1.00 | 1.00 | 1.00 |
Male | 0.67 (0.54–0.84)*** | 0.95 (0.40–2.23) | 0.70 (0.56–0.88)** |
Primary site | |||
Extremity | 1.00 | 1.00 | 1.00 |
Other | 2.25 (1.79–2.82)*** | 1.73 (0.68–4.36) | 2.23 (1.76–2.82)*** |
Stage at diagnosisa | |||
Localised | 1.00 | 1.00 | 1.00 |
Metastatic | 6.15 (4.75–7.95)*** | 42.4 (12.53–143.70)*** | 4.86 (3.74–6.33)*** |
Quintile of the income domain of the index of multiple deprivation 2010 | |||
Least deprived | 1.11 (0.78–1.59) | 2.39 (0.47–12.19) | 1.17 (0.81–1.68) |
2 | 1.34 (0.95–1.91) | 1.68 (0.31–9.16) | 1.33 (0.93–1.90) |
3 | 1.00 | 1.00 | 1.00 |
4 | 1.18 (0.83–1.68) | 0.61 (0.13–2.83) | 1.22 (0.84–1.76) |
Most deprived | 1.48 (1.03–2.12)* | 2.35 (0.54–10.16) | 1.27 (0.88–1.84) |
Time varying covariate | |||
Primary site | 0.76 (0.64–0.91)** | – | 0.73 (0.61–0.88)** |